The Biomarker: Melanoma

James F. Donohue, MD
Video Categories: The Biomarker

PMO is pleased to offer the department “The Biomarker” to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. This month, we focus on KIT mutations in melanoma patients. Dr Sanjiv Agarwala provides his insights on this provocative topic.
September 20, 2013

Demonstrating the Value of Personalized Medicine

Jayson Slotnik provides an overview of the issues in demonstrating the value of personalized medicine tests and products

August 15, 2016

Addressing Optimal Surgical Conditions

Phillip Boudreaux, MD, discusses the difference in patient profiles in sick patients who undergo emergency surgeries versus healthier patients who undergo elective surgeries.